A growing number of clinicians rely on AdaptDx to detect age-related macular degeneration in their adult patients. Our customers tell the story of how they’re fighting against blindness caused by AMD.
Thanks to the comprehensive AMD Excellence training program from MacuLogix, each staff member - from the front desk and optical to technicians and billing - understands the important role they play in AMD care.
The impact of the AdaptDx on my patient care and practice revenue has been phenomenal!
Now that we are using the AdaptDx to diagnose AMD earlier and actively manage disease progression, I’m confident we will improve outcomes in both eyes by catching CNV before significant vision loss occurs.
The AdaptDx is simple for the patient and takes little staff training to become proficient at administering. Analyzing the data by the doctor only takes seconds and is very simple to interpret. This allows more time to discuss with the patient the results and the plan of action when needed.
AdaptDx more than paid for itself within the first few months.
Equipment companies usually ship you a big box and you never hear from them again. That was not the case with MacuLogix and their AdaptDx. They spent 2 days with us and did a fantastic job training our whole office!
I strongly believe that if we can catch AMD at a very early stage and be really proactive with recommending supplements, blue light filters, sunglasses, telling them to watch their BMI, their cholesterol levels, that we can stop or slow this down and maintain their vision the rest of their life.
Our doctors decided that we should be doing an AMD screening for our patients over the age of 65 no matter what. Photos and looking at the macula is just not enough. If you look at the statistics, it makes more sense to do an AdaptDx test on this population than it does to take a tonometry reading to screen for glaucoma!! We decided we wanted to be more proactive and take better care of our patients. Using the AdaptDx to find subclinical AMD enables us to do just that.
The MacuLogix AdaptDx dark adaptometer is the first device of its kind that will provide me with a quantifiable result that can be monitored over time. It allows me to track the function of a patient’s macular rod photoreceptors, which is a very specific biomarker for AMD. In my opinion, this device is a game-changer in any practice committed to preserving sight. Having the ability to diagnose AMD in patients with symptoms but little to no clinical signs has taken my confidence to the next level.
Outside of the lane, there are four essential diagnostic tests that I couldn’t practice without: OCT, fundus camera, visual field, and the AdaptDx.